BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2026.
World J Gastroenterol. Feb 21, 2026; 32(7): 113973
Published online Feb 21, 2026. doi: 10.3748/wjg.v32.i7.113973
Figure 3
Figure 3 Lactate metabolism heterogeneity intrahepatic cholangiocarcinoma malignant cells. A: Distribution of lactate metabolism (LM) activity scores in malignant epithelial cells. Cells were stratified into low-LM (LLM) (< 2.38), intermediate-LM (ILM), and high-LM (HLM) (> 2.83) activity groups; B: Spatial distribution of LLM, ILM, and HLM subgroups; C: Density maps illustrating distinct spatial patterns of LM activity; D: Differentiation potential across malignant cells; E: CytoTRACE scores among subgroups; F: The co-expression relationship of LM scoring and CytoTRACE score; G: Correlation plot of LM activity and CytoTRACE scores (r = 0.60, Pearson), showing a strong positive association; H: The development trajectory of malignant epithelial cell subpopulation. cP < 0.001. LM: Lactate metabolism; LLM: Low-lactate metabolism; ILM: Intermediate-lactate metabolism; HLM: High-lactate metabolism; UMAP: Uniform manifold approximation and projection; CI: Confidence interval.


Write to the Help Desk